Quest Diagnostics, Inc (NYSE: DGX) is 7.81% higher on its value in year-to-date trading and has touched a low of $123.30 and a high of $167.08 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The DGX stock was last observed hovering at around $164.87 in the last trading session, with the day’s loss setting it -2.23%.
Currently trading at $162.64, the stock is 3.91% and 4.06% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.92 million and changing -1.35% at the moment leaves the stock 8.69% off its SMA200. DGX registered 31.39% gain for a year compared to 6-month gain of 10.72%. The firm has a 50-day simple moving average (SMA 50) of $156.312 and a 200-day simple moving average (SMA200) of $149.4638.
The stock witnessed a 6.81% loss in the last 1 month and extending the period to 3 months gives it a 5.38%, and is -0.93% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.17% over the week and 2.39% over the month.
Quest Diagnostics, Inc (DGX) has around 48000 employees, a market worth around $18.15B and $9.87B in sales. Current P/E ratio is 21.13 and Fwd P/E is 15.45. Profit margin for the company is 8.77%. Distance from 52-week low is 31.91% and -2.66% from its 52-week high. The company has generated returns on investments over the last 12 months (6.70%).
with sales reaching $2.65B over the same period.The EPS is expected to grow by 8.77% this year, but quarterly earnings will post 9.19% year-over-year. Quarterly sales are estimated to grow 12.01% in year-over-year returns.
1238.0 institutions hold shares in Quest Diagnostics, Inc (DGX), with institutional investors hold 92.39% of the company’s shares. The shares outstanding are 111.61M, and float is at 111.06M with Short Float at 2.04%. Institutions hold 91.99% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 13.95 million shares valued at $1.91 billion. The investor’s holdings represent 12.5692 of the DGX Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 10.06 million shares valued at $1.38 billion to account for 9.0625 of the shares outstanding. The other top investors are STATE STREET CORP which holds 5.19 million shares representing 4.6781 and valued at over $710.77 million, while VICTORY CAPITAL MANAGEMENT INC holds 3.4988 of the shares totaling 3.88 million with a market value of $531.6 million.
Quest Diagnostics, Inc (DGX) Insider Activity
Still, SEC filings show that on Jan 31 ’25, DELANEY MARK E (Officer) Proposed Sale 2,615 shares at an average price of $164.85 for $0.43 million. The insider now directly holds shares of Quest Diagnostics, Inc (DGX).
